AI-64310-CRFT

306 / 658

Part of Thermo Fisher Scientific
Legal Notices: ©2011 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. This
information is presented as an example of the capabilities of Thermo Fisher Scientific Inc. products. It is not intended to encourage use of these products in any
manners that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all
countries. Please consult your local sales representative for details.
Thermo Fisher Scientific,
San Jose, CA USA is ISO Certified.
AN63438_E 06/11S
In addition to these
offices, Thermo Fisher
Scientific maintains
a network of represen­
tative organizations
throughout the world.
Africa-Other
+27 11 570 1840
Australia
+61 3 9757 4300
Austria
+43 1 333 50 34 0
Belgium
+32 53 73 42 41
Canada
+1 800 530 8447
China
+86 10 8419 3588
Denmark
+45 70 23 62 60
Europe-Other
+43 1 333 50 34 0
Finland/Norway/
Sweden
+46 8 556 468 00
France
+33 1 60 92 48 00
Germany
+49 6103 408 1014
India
+91 22 6742 9434
Italy
+39 02 950 591
Japan
+81 45 453 9100
Latin America
+1 561 688 8700
Middle East
+43 1 333 50 34 0
Netherlands
+31 76 579 55 55
New Zealand
+64 9 980 6700
Russia/CIS
+43 1 333 50 34 0
South Africa
+27 11 570 1840
Spain
+34 914 845 965
Switzerland
+41 61 716 77 00
UK
+44 1442 233555
USA
+1 800 532 4752
Figure 6. Extract of a TraceFinder Target Screening Long Report showing ion chromatograms and MS/MS
spectra of EDDP detected in urine
Figure 6 shows an extract of the long report generated
by TraceFinder software, showing the comparison between
experimental spectra and library spectra for each com-
pound. All of the spectra showed a high matching score
confirming the presence of cocaine, methadone, and their
metabolites in the urine sample.
Conclusion
The TSQ Quantum Access MAX™ with T-SRM and
QED-RER acquisition mode was used to screen toxic
compounds and their metabolites in urine. This screening
approach provides rapid sample preparation, ease-of-use,
sensitivity, specificity, and a low cost per sample analysis
for forensic toxicology laboratories.
..